Danaparoid reduces transplant-related mortality in stem cell transplantation for children.

about

Danaparoid reduces transplant-related mortality in stem cell transplantation for children.

Item

http://www.wikidata.org/entity/Q48119892

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Danaparoid reduces transplant- ...... transplantation for children.

@en

Danaparoid reduces transplant- ...... transplantation for children.

@nl

type

Item

label

Danaparoid reduces transplant- ...... transplantation for children.

@en

Danaparoid reduces transplant- ...... transplantation for children.

@nl

prefLabel

Danaparoid reduces transplant- ...... transplantation for children.

@en

Danaparoid reduces transplant- ...... transplantation for children.

@nl

P1476

Danaparoid reduces transplant- ...... transplantation for children.

@en

P2093

Atsushi Narita

http://www.w3.org/2001/XMLSchema#string

Hideki Muramatsu

http://www.w3.org/2001/XMLSchema#string

Hirotoshi Sakaguchi

http://www.w3.org/2001/XMLSchema#string

Kimikazu Matsumoto

http://www.w3.org/2001/XMLSchema#string

Nao Yoshida

http://www.w3.org/2001/XMLSchema#string

Nobuhiro Watanabe

http://www.w3.org/2001/XMLSchema#string

Sayoko Doisaki

http://www.w3.org/2001/XMLSchema#string

Yuko Sekiya

http://www.w3.org/2001/XMLSchema#string

P2860

Danaparoid: a review of its use in thromboembolic and coagulation disorders

Danaparoid sodium.

Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults

A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in acute leukemia patients.

Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.

P31

scholarly article

P356

10.1111/PETR.13099

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nozomu Kawashima

Koji Kato

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29239087

http://www.w3.org/2001/XMLSchema#string